Array Biopharma (ARRY) Tops Q3 EPS by 38c
Tweet
Share
E-mailGet Alerts ARRY Hot Sheet
Price: $5.05 -2.32%
Financial Fact:
Research and development for proprietary programs: 46.56M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Research and development for proprietary programs: 46.56M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Array Biopharma (NASDAQ: ARRY) reported Q3 EPS of $0.37, $0.38 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $6.6 million versus the consensus estimate of $6 million.
For earnings history and earnings-related data on Array Biopharma (ARRY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Star Equity Holdings (STRR) Misses Q2 EPS by 8c
- Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
